SubHero Banner

B. Braun Medical – Recall of ceftazidime

April 17, 2020 - B. Braun Medical announced a voluntary, consumer-level recall of one lot of ceftazidime and dextrose for injection because test results were found to exceed the specification limits for High Molecular Weight Polymers (HMWP) at the nineteen month stability interval.

Download PDF